Anika Therapeutics Inc. (ANIK) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Anika Therapeutics Inc.

    NASDAQ: ANIK · Real-Time Price · USD
    9.07
    -0.05 (-0.55%)
    At close: Oct 03, 2025, 3:59 PM
    9.00
    -0.77%
    After-hours: Oct 03, 2025, 06:27 PM EDT

    Anika Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -4.3 -4.02 -29.01 124.82
    PEG Ratio
    		 0.13 -0.01 0.06 -1.07
    PS Ratio
    		 2.02 1.99 2.76 3.49
    PB Ratio
    		 1.57 1.56 1.51 1.80
    P/FCF Ratio
    		 -103.95 -46.03 -140.07 158.57
    P/OCF Ratio
    		 44.85 -185.74 97.76 61.45
    OCF/S Ratio
    		 0.05 -0.01 0.03 0.06
    Debt / Equity Ratio
    		 0.17 0.14 0.11 0.07
    Quick Ratio
    		 3.85 3.76 4.65 4.45
    Current Ratio
    		 4.88 5.26 6.07 5.66
    Asset Turnover
    		 0.59 0.62 0.45 0.43
    Interest Coverage
    		 -2.18 n/a n/a n/a
    Return on Equity
    		 -0.37 -0.39 -0.05 0.01
    Return on Assets
    		 -0.28 -0.31 -0.04 0.01
    Return on Invested Capital
    		 -0.09 n/a -0.05 0.01
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.63 0.50 0.60 0.56
    Net Profit Margin
    		 -0.47 -0.5 -0.1 0.03
    Pretax Profit Margin
    		 -0.02 -0.51 -0.12 0.02
    Operating Profit Margin
    		 -0.04 0.01 -0.12 0.02
    FCF Margin
    		 -0.02 -0.04 -0.02 0.02
    EBITDA Margin
    		 0.03 -0.07 0.12 0.02

    Add to Watchlist